Immunogenicity and Safety Study of a Single Injection of GSK Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral (2008 - 2009 Season) in Adults Aged 18 to 60 Years and Over 60 Years.
Phase of Trial: Phase III
Latest Information Update: 23 Oct 2018
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 30 Oct 2008 Actual patient number (110) added as reported by ClinicalTrials.gov.
- 30 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Aug 2008 New trial record.